
Plonmarlimab
CAS No. 2377482-36-3
Plonmarlimab( —— )
Catalog No. M36822 CAS No. 2377482-36-3
Plonmarlimab (TJ003234) is an anti-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody with potential antiviral activity for the study of immune diseases and novel coronavirus infections.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 453 | Get Quote |
![]() ![]() |
5MG | 687 | Get Quote |
![]() ![]() |
10MG | 937 | Get Quote |
![]() ![]() |
25MG | 1371 | Get Quote |
![]() ![]() |
50MG | 1812 | Get Quote |
![]() ![]() |
100MG | 2421 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePlonmarlimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionPlonmarlimab (TJ003234) is an anti-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody with potential antiviral activity for the study of immune diseases and novel coronavirus infections.
-
DescriptionPlonmarlimab (TJ003234) is an anti-GM-CSF monoclonal antibody. Plonmarlimab can be used for research of rheumatoid arthritis and COVID-19.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetCSF1R
-
Recptorc-Fms | SARS-CoV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2377482-36-3
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bonaventura A, et al. Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies. Front Immunol. 2020 Jul 3;11:1625. ?
molnova catalog



related products
-
Otilimab
Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF).
-
Axatilimab
Axatilimab (SNDX-6352) is a human IgG4 antibody targeting the colony-stimulating factor 1 receptor (CSF-1R), which can be used for the study of immune system disorders and respiratory diseases.
-
Plonmarlimab
Plonmarlimab (TJ003234) is an anti-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody with potential antiviral activity for the study of immune diseases and novel coronavirus infections.